Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report

Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report

Since 2004, pegylated interferon (P-IFN) in combination with ribavirin has become the optimal choice of therapy for chronic hepatitis C virus (HCV) infection. IFN α-2b suppresses HCV replication and restores elevated serum aminotransferase levels, leading to improvements in the histological changes...

Full description

Bibliographic Details
Main Authors:	Raúl Carrillo-Esper, Daniela González-Avila, Marittza Uribe-Ríos, Nahum Méndez-Sánchez, MD, PhD.
Format:	Article
Language:	English
Published:	Elsevier 2008-01-01
Series:	Annals of Hepatology
Subjects:	Chronic hepatitis C liver cirrhosis pegylated interferon interstitial pneumonitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119318952

Similar Items

Pegylated Interferons and Their Use in Clinical Practice
by: Alpay AZAP, et al.
Published: (2003-12-01)

Interstitial pneumonitis caused by everolimus treatment
by: Nilufer Aykac Kongar, et al.
Published: (2016-03-01)

Parasitic infestation of lung: An unusual cause of interstitial pneumonitis
by: Parth Shah, et al.
Published: (2016-01-01)

Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature
by: Renata Ferrarotto, et al.
Published: (2011-12-01)

Low-dose methotrexate-induced acute interstitial pneumonitis: Report of two cases from South India and review of literature
by: Ramya Iyyadurai, et al.
Published: (2016-01-01)

Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
by: Ricardo Jiménez-Méndez, et al.
Published: (2010-01-01)

Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-Two case reports
by: Vinod S. Hegade, M.D. MRCP, et al.
Published: (2013-07-01)

Pulmonary hazards of chronic hepatitis C virus infection treatment with Pegylated interferon and ribavirin vs. untreated patients
by: Sanaa Elhelaly, et al.
Published: (2013-04-01)

Unusual variant of pulmonary lesion (lymphocytic interstitial pneumonitis) in systemic lupus erythematosus
by: O V Blagova, et al.
Published: (2008-05-01)

Pulmonary alveolar microlithiasis and interstitial pneumonitis: a case report of the west of Iran
by: Ramezani Mazaher, et al.
Published: (2019-12-01)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
by: Zheng C, et al.
Published: (2019-04-01)

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
by: Marisa Boff Costa, et al.
Published: (2018-01-01)

Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
by: Hisham O. Akbar, et al.
Published: (2002-04-01)

Reversed halo sign as initial manifestation of interstitial pneumonitis associated with Sjögren’s syndrome
by: M.A. Duarte-Millán, et al.
Published: (2017-07-01)

Characterization of lymphocyte populations in nonspecific interstitial pneumonia*
by: Limper Andrew H, et al.
Published: (2005-11-01)

Early‐onset interstitial pneumonitis in a patient with advanced non‐small cell lung cancer treated with crizotinib and osimertinib
by: Yuan Cheng, et al.
Published: (2021-03-01)

Evaluation of the Results of Patients Treated By Pegylated Interferon Alpha Therapy
by: Çiğdem PAPİLA, et al.
Published: (2015-09-01)

Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease
by: V.D. Villgran, et al.
Published: (2021-01-01)

Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report
by: Jacek Roliński, et al.
Published: (2018-04-01)

Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer
by: Omalkhair Abulkhair, et al.
Published: (2011-04-01)

EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
by: K. V. Zhdanov, et al.
Published: (2018-01-01)

Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report
by: Yoshinori Yanai, et al.
Published: (2019-07-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Organizing pneumonia causing severe respiratory failure as a complication of interferon-α therapy
by: Maged Hassan, et al.
Published: (2016-02-01)

Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar
by: Mohammad Abu-Tineh, et al.
Published: (2020-03-01)

Switching to an alternative ALK-inhibitor after alectinib-induced pneumonitis resulted in resolution of this adverse event
by: Evan Bryson, et al.
Published: (2020-12-01)

Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
by: Elson Vidal Martins Jr., et al.
Published: (2009-11-01)

PEDIATRIC HYPERSENSITIVE PNEUMONITIS POSITIVE EXPERIENCE IN MANAGEMENT
by: N. S. LEV, et al.
Published: (2017-07-01)

Can pegylated interferon improve the outcome of polycythemia vera patients?
by: Elena Crisà, et al.
Published: (2017-01-01)

Lymphoid interstitial pneumonitis in a newly diagnosed late presenter of human immunodeficiency virus infection: a case report
by: V. Petrakis, et al.
Published: (2021-02-01)

Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study
by: S K Agarwal, et al.
Published: (2016-01-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine
by: Mandrik Olena, et al.
Published: (2015-01-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Interstitial pneumonia associated to peginterferon alpha-2a: A focus on lung function
by: Arturo Cortés-Telles
Published: (2016-01-01)

Hypersensitivity pneumonitis: an overlooked cause of cough and dyspnea
by: Ryan S. D’souza, et al.
Published: (2017-04-01)

Chronic interstitial pneumonitis in dogs naturally infected with Leishmania (Leishmania) chagasi: a histopathological and morphometric study
by: Gonçalves Ricardo, et al.
Published: (2003-01-01)

Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting
by: Sergio Sabbatani, et al.

Lymphocytic interstitial pneumonitis (LIP)-The liver and the lung
by: A. Koulaouzidis, et al.
Published: (2006-07-01)

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users
by: Ružić Maja, et al.
Published: (2010-01-01)

Cannot write session to /tmp/vufind_sessions/sess_n8di9r4nudcjgk9c5lg6i20thc